Literature DB >> 18300322

Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.

Jean L Raphael1, Aditi Kamdar, Tao Wang, Hao Liu, Donald H Mahoney, Brigitta U Mueller.   

Abstract

BACKGROUND: Day hospital (DH) management for patients with sickle cell disease (SCD) experiencing uncomplicated vaso-occlusive pain crises has been utilized as an alternative care delivery system to inpatient hospitalization. The objective of this study was to determine whether DH management results in shorter length of stay compared to inpatient care. PROCEDURE: We conducted a retrospective cohort study with 35 DH admissions and 35 inpatient admissions for children with SCD presenting with uncomplicated vaso-occlusive crises (VOCs). A DH admission was defined as a minimum of two consecutive days of aggressive pain management as an outpatient, including intravenous hydration and analgesics, supported by home treatment over night with oral analgesic and anti-inflammatory agents. We gathered data on demographics, pain scores, length of stay, admission charges, and needs for persistent care.
RESULTS: DH care resulted in a 39% reduction of the average length of stay compared to inpatient admissions. Multivariate linear regression demonstrated that the location of patient care for VOCs was a significant predictor of length of stay (P < 0.0006) after controlling for patient characteristics, severity of illness, and disease history.
CONCLUSIONS: We conclude that a dedicated DH facility has the potential to provide efficient and timely management of uncomplicated VOCs through reduction of length of stay. This delivery care system may be particularly relevant for children who are significantly impacted by inpatient hospitalization. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18300322     DOI: 10.1002/pbc.21537

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  11 in total

1.  Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.

Authors:  Hussain R Yusuf; Hani K Atrash; Scott D Grosse; Christopher S Parker; Althea M Grant
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.

Authors:  Sophie Lanzkron; C Patrick Carroll; Peter Hill; Mandy David; Nicklaine Paul; Carlton Haywood
Journal:  Am J Hematol       Date:  2015-02-25       Impact factor: 10.047

Review 3.  Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease.

Authors:  Paul Telfer; Banu Kaya
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Benchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospital.

Authors:  Abi Vijenthira; Jennifer Stinson; Jeremy Friedman; Lori Palozzi; Anna Taddio; Dennis Scolnik; Charles Victor; Melanie Kirby-Allen; Fiona Campbell
Journal:  Pain Res Manag       Date:  2012 Jul-Aug       Impact factor: 3.037

5.  Association of care in a medical home and health care utilization among children with sickle cell disease.

Authors:  Jean L Raphael; Tiffany L Rattler; Marc A Kowalkowski; David C Brousseau; Brigitta U Mueller; Thomas P Giordano
Journal:  J Natl Med Assoc       Date:  2013       Impact factor: 1.798

6.  The impact of race and disease on sickle cell patient wait times in the emergency department.

Authors:  Carlton Haywood; Paula Tanabe; Rakhi Naik; Mary Catherine Beach; Sophie Lanzkron
Journal:  Am J Emerg Med       Date:  2013-02-04       Impact factor: 2.469

7.  Current management of sickle cell anemia.

Authors:  Patrick T McGann; Alecia C Nero; Russell E Ware
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

8.  Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects.

Authors:  Julie Kanter; Wally R Smith; Payal C Desai; Marsha Treadwell; Biree Andemariam; Jane Little; Diane Nugent; Susan Claster; Deepa G Manwani; Judith Baker; John J Strouse; Ifeyinwa Osunkwo; Rosalyn W Stewart; Allison King; Lisa M Shook; John D Roberts; Sophie Lanzkron
Journal:  Blood Adv       Date:  2020-08-25

9.  Emergency Department (ED), ED Observation, Day Hospital, and Hospital Admissions for Adults with Sickle Cell Disease.

Authors:  David M Cline; Susan Silva; Caroline E Freiermuth; Victoria Thornton; Paula Tanabe
Journal:  West J Emerg Med       Date:  2018-02-12

10.  Caregiver experiences with accessing sickle cell care and the use of telemedicine.

Authors:  Seethal A Jacob; Roua Daas; Anna Feliciano; Julia E LaMotte; Aaron E Carroll
Journal:  BMC Health Serv Res       Date:  2022-02-22       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.